Michael J Weyant
Overview
Explore the profile of Michael J Weyant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
122
Citations
1124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pham D, Park J, Wang H, Subramanian M, Weyant M, Suzuki K
Clin Lung Cancer
. 2024 Dec;
PMID: 39719714
Background: Current staging work-up does not capture all occult lymph node (OLN) disease. We sought to determine if Computer Assisted Nodule Analysis and Risk Yield (CANARY) analysis could help distinguish...
2.
Park J, Pham D, Nilsson K, Ramsey L, Morris D, Khandhar S, et al.
Clin Lung Cancer
. 2024 Dec;
26(2):140-145.
PMID: 39645529
Objective: Thoracic Enhanced Recovery with Ambulation after Surgery (T-ERAS) protocol at our institution includes ambulation into the operating room and 250-feet ambulation within 1 hour of extubation. We compared the...
3.
Park J, Pham D, Wang H, Khandhar S, Weyant M, Suzuki K
J Thorac Dis
. 2024 Nov;
16(10):6475-6482.
PMID: 39552856
Background: As sub-lobar resection becomes acceptable for lung cancer ≤2 cm, a preoperative marker of tumor aggressiveness to choose an appropriate extent of resection becomes necessary. We sought to assess...
4.
Park J, Yalamanchili S, Brown Z, Myers A, Weyant M, Mahajan A, et al.
Clin Lung Cancer
. 2024 Sep;
25(7):619-623.
PMID: 39245618
Introduction: Lung cancer survival is significantly improved with early detection. However, lung cancer screening (LCS) uptake remains low despite national recommendations. Our aim was to determine whether implementation of an...
5.
Gouchoe D, Sanchez P, DCunha J, Bermudez C, Daneshmand M, Davis R, et al.
J Thorac Cardiovasc Surg
. 2024 Mar;
168(3):724-734.e7.
PMID: 38508486
Objective: Donation after circulatory death (DCD) donors offer the ability to expand the lung donor pool and ex vivo lung perfusion (EVLP) further contributes to this ability by allowing for...
6.
Dyas A, Stuart C, Fei Y, Cotton J, Colborn K, Weyant M, et al.
J Thorac Dis
. 2024 Mar;
16(2):1141-1150.
PMID: 38505021
Background: Surgical diagnostic lung biopsy (DLB) is performed to guide the management of pulmonary disease with unclear etiology. However, the utilization of surgical DLB in critically ill patients remains unclear....
7.
Dyas A, Stuart C, Bronsert M, Kelleher A, Bata K, Cumbler E, et al.
Ann Surg
. 2024 Feb;
279(6):1062-1069.
PMID: 38385282
Objective: We sought to evaluate how implementing a thoracic enhanced recovery after surgery (ERAS) protocol impacted surgical outcomes after elective anatomic lung resection. Background: The effect of implementing the ERAS...
8.
Mahajan A, Bari M, Collar N, Chakravorty S, Duong D, Suzuki K, et al.
J Bronchology Interv Pulmonol
. 2023 Sep;
31(2):126-131.
PMID: 37702527
Background: The incidence of pneumothorax after bronchoscopic lung volume reduction (BLVR) using Zephyr (Pulmonx Corporation) endobronchial valves is ~26%. Many patients who develop a postprocedural pneumothorax require chest tube placement....
9.
Madsen H, Stuart C, Wojcik B, Dyas A, Hunt A, Helmkamp L, et al.
J Thorac Dis
. 2023 Jul;
15(6):2984-2996.
PMID: 37426131
Background: Early recognition of esophageal perforation may prevent morbidity and mortality, and accurate diagnostic imaging facilitates triage. Stable patients with suspected perforation may be transferred to higher levels of care...
10.